CRNA raises $59.0M (Norway, Aug 2026)
Find the investors funding Health rounds
326,000+ VC, angel and family-office profiles — direct emails, check sizes and stage filters.
CRNA: Up to 60x gene expression boost, 20+ collaborations, and NOK 620m raised secure growth to 2030 - TradingView
CRNA is focused on enhancing gene expression, achieving up to a 60x boost. The company has established over 20 collaborations and has raised NOK 620 million to support its growth through 2030.
CRNA: Up to 60x gene expression boost, 20+ collaborations, and NOK 620m raised secure growth to 2030 TradingView
| Aug 24, 2026 | Newcode | $13.5M | Series A | Norway |
| Aug 17, 2026 | Birdsview | $4.0M | — | Norway |
| Aug 10, 2026 | Visoid | $2.5M | — | Norway |
| Aug 07, 2026 | Volta Infra Holdings | $300.0M | Series A | Norway |
1,081 investors back startups in Norway
You just read who funded CRNA. The same database has the investors behind every other round — with verified emails, check sizes and the stages they actually write at.
Free account: 15 investor contact unlocks a month, no card required.